255 related articles for article (PubMed ID: 16385517)
1. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
Distler JH; Jüngel A; Caretto D; Schulze-Horsel U; Kowal-Bielecka O; Gay RE; Michel BA; Müller-Ladner U; Kalden JR; Gay S; Distler O
Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
3. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
Galindo M; Santiago B; Rivero M; Rullas J; Alcami J; Pablos JL
Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
Ong VH; Evans LA; Shiwen X; Fisher IB; Rajkumar V; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
6. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro.
Del Galdo F; Jiménez SA
Arthritis Rheum; 2007 Oct; 56(10):3478-88. PubMed ID: 17907195
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
9. A CD40-CD154 interaction in tissue fibrosis.
Kawai M; Masuda A; Kuwana M
Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
11. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.
Fukasawa C; Kawaguchi Y; Harigai M; Sugiura T; Takagi K; Kawamoto M; Hara M; Kamatani N
Eur J Immunol; 2003 Oct; 33(10):2792-800. PubMed ID: 14515263
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
[TBL] [Abstract][Full Text] [Related]
14. Increased interleukin-17 production in patients with systemic sclerosis.
Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha.
Bouchelouche K; Andresen L; Alvarez S; Nordling J; Nielsen OH; Bouchelouche P
J Urol; 2006 Feb; 175(2):760-5. PubMed ID: 16407046
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
[TBL] [Abstract][Full Text] [Related]
17. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.
Distler JH; Akhmetshina A; Schett G; Distler O
Rheumatology (Oxford); 2009 Feb; 48(2):98-103. PubMed ID: 18984611
[TBL] [Abstract][Full Text] [Related]
20. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
